In this review:
Management of hyperglycemia in type 2 diabetes
Glargine vs. sitagliptin in metformin-uncontrolled type 2 diabetes
Exenatide vs. glimepiride in type 2 diabetes with metformin failure
Quality improvement strategies in diabetes management
Basal insulin and CV and other outcomes in dysglycaemia
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
Insulin and Cancer
Please login below to download this issue (PDF)